My feeling is that the only real hope is that mistakes were made in data processing, which would mean that the actual research results could still be good. But I consider the probability of this scenario to be small, and even if this miracle were to happen, lawsuits would likely arise against Diamyd for providing false information to the market, which would then anyway mean a really tough path forward for Diamyd.
Now the stock is close to its book value, so I decided to salvage what I could and move on. In difficult times, it’s important to hold on to hope and keep moving forward. It’s always possible to start with a clean slate, even if it might feel insurmountable at times! There is hope as long as you don’t give up!